Navigation Links
ENDEAVOR III Trial Reports Key Findings on New-generation Stent

New data reported at the 30th Annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions (SCAI), May 912, 2007, in Orlando, FL, will offer clues to the fate of a new-generation drug-eluting stent that is vying for a place in the treatment of coronary artery disease.

The Endeavor III trial randomly assigned 436 patients treated at 30 medical centers in the United States to treatment with the investigational Endeavor stent (Medtronic, Minneapolis) or the Cypher stent (Cordis Johnson & Johnson, Miami Lakes, FL). The Endeavor stent is coated with zotarolimus, a medication that, like the Cyphers sirolimus coating, reduces renarrowing of the artery by preventing the growth of scar tissue inside the stent.

Initial data showed that procedural success was higher with the new Endeavor stent, which is more flexible and is considered easier to implant than the Cypher stent. However, at 8 months, the Endeavor stent fell short in angiographic studies, showing significantly greater scar tissue growth, or late loss, in the inner diameter of the artery as compared to the Cypher stent. At 12 months, clinical outcomes were equivalent with the two stents: The combined rates of death, heart attack, and repeat procedures were 8.2 percent in both groups of patients.

At the Orlando SCAI meeting, Martin Leon, M.D., FSCAI, a professor of medicine and associate director of the Center for Interventional Vascular Therapy at Columbia University Medical Center in New York City, will report 2-year clinical outcomes from the Endeavor III trial.

"Long-term follow-up will further clarify not only safety with the zotarolimus-eluting stent but also whether early angiographic disparities translate into differences in late clinical restenosis," he said.

The Endeavor III trial is 1 of 5 studies gathering the data necessary for market approval of the new stent by the Food and Drug Administration.


'"/>




Page: 1

Related medicine news :

1. Results Of Human Trials Of Hungarian Bird-Flu Vaccine Expected Today
2. Vaccine For Dengue Fever On Trial In Asia-Pacific
3. DNA Vaccine Trials Against HIV Virus In Sweden Nurture Hope
4. Clinical Trials of New Drug Febuxostat Show Promise in Gout Treatment
5. Sex, Race Influence Lung Cancer Trial Participation
6. Clinical Trials Of New Anti-Cancer Drug To Be Initiated In New Zealand
7. Diarrhea Vaccine Trials Promises Prevention of Rotavirus Infection
8. New Generation Clinical Trials Could Save Time And Money, Improve Patient Care
9. China Begins Human Trials For HIV/AIDS Drug
10. Patients Should Be Entitled to "Humane Compensation" if Drug Trials Go Wrong
11. HIV/AIDS Vaccine Trial To Be Initiated Soon
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: ENDEAVOR III Trial Reports Key Findings New generation Stent

(Date:7/22/2014)... 22, 2014 For the past nine ... have been working in tandem to help thousands of ... access to care, and help survivors connect to resources ... foundations expanded their partnership to include referrals from PAF ... with the other practical, emotional, and financial issues that ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Get ... the Immune Deficiency Foundation (IDF) to provide ... portal that will allow them to electronically track their ... manage their illnesses. It will also allow those patients ... to consent to have their data shared with ...
(Date:7/22/2014)... Atreo Services will be presenting its full range ... accessories in booth #1423 at the American Society for ... Chicago, Ill., Aug. 3-6. , Atreo will display its ... well as its selection of liners and inserts designed ... In addition, representatives will be available to talk about ...
(Date:7/22/2014)... 2014 Altec Products, Inc. , ... announced today their Gold Sponsorship of Sage Summit ... Bay Hotel and Casino in Las Vegas, Nevada. The ... thousands interested in taking advantage of the many opportunities ... business problems and educate themselves on the latest enterprise ...
(Date:7/22/2014)... CA (PRWEB) July 22, 2014 Dr. ... to announce the launch of a new website dedicated ... The website can be found at DrKamrava.com . ... provide patients with a knowledgeable and trustworthy source for ... they suffer from hemorrhoids, fissures, gallstones, colon cancer, hernias, ...
Breaking Medicine News(10 mins):Health News:LIVESTRONG Foundation and Patient Advocate Foundation Expand Partnership to Support the Needs of Cancer Patients and Survivors Nationwide 2Health News:LIVESTRONG Foundation and Patient Advocate Foundation Expand Partnership to Support the Needs of Cancer Patients and Survivors Nationwide 3Health News:Get Real Health to Partner with Immune Deficiency Foundation 2Health News:Get Real Health to Partner with Immune Deficiency Foundation 3Health News:Atreo Services to Introduce Pneumatic Tube System Solutions at ASHE Annual Conference 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 3Health News:Los Angeles Doctor Launches Brand New Website for Colorectal Surgery and Treatment 2Health News:Los Angeles Doctor Launches Brand New Website for Colorectal Surgery and Treatment 3
... Texas, M. D. Anderson Cancer Center, John Mendelsohn, has been ... . This announcement was made in Paris, for his path ... Foundation which is located at the Tel Aviv University distributed ... million each to laureates chosen in areas where the contribution ...
... be the reason why isolated women are less vulnerable to falling ... ,The study is an eye-opener to the upcoming proof ... holds a clue to the reason why socially isolated men are ... studies have shown a connection between stress and immune function. But ...
... fall flat on its face, unless the government takes a leading ... local level work is going on in good measure, governments need ... area. The public Health Minister, Caroline Flint has confirmed the measures ... has sent the NHS expenditure sky rocketing almost ?1bn a year ...
... School of Public Health are one of the 14 ... Environmental Health Sciences// (NIEHS) to study the association between ... is a new study to control the rising obesity ... an individual’s body size. Working with various city departments, ...
... by Thomas Arcury, Ph.D., lead researcher, from Wake Forest University ... Carolina// widely use folk or home remedies, such as taking ... use is largely limited to home remedies, vitamins and minerals. ... more about what complementary and alternative medicine (CAM) therapies older ...
... to allegations that a perceived problem with the computer system ... schedule of thousands of babies and young children. ... initiative by the Government, to track the immunization schedule of ... that nearly 3,000 children would find themselves in the throes ...
Cached Medicine News:Health News:Women Portray Stronger Immune Response As Compared to Men, Study Suggests 2Health News:Inclination of North Carolina’s Elderly Population towards Home Remedie 2
(Date:7/21/2014)... , July 21, 2014 ... Research titled, "Global biosimilars/follow-on-biologics market (types, applications and ... Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and ... biosimilars market would reach $35 billion by 2020 ... penetration with clearer regulatory pathways in developed markets ...
(Date:7/21/2014)... LOS ANGELES , July 21, 2014 ... Procurement Agency (LOPA) is utilizing the CompuMed, ... (OPO) Solution to improve donor organ recovery. ... platform to provide real-time access to its ... critical care consulting.      (Logo: ...
(Date:7/21/2014)... 2014  PowerVision, Inc., a medical device company ... today announced that Douglas D. Koch , ... Ophthalmology, and Professor of Ophthalmology, at Baylor College ... Board. As a recipient of ... Ophthalmology Lifetime Achievement award, Koch will join the ...
Breaking Medicine Technology:Biosimilars/Follow-on-Biologics Market is Expected to Reach $35 Billion, Globally, by 2020 2Biosimilars/Follow-on-Biologics Market is Expected to Reach $35 Billion, Globally, by 2020 3Biosimilars/Follow-on-Biologics Market is Expected to Reach $35 Billion, Globally, by 2020 4Louisiana Organ Procurement Agency Leveraging CompuMed to Secure More Donor Hearts 2Louisiana Organ Procurement Agency Leveraging CompuMed to Secure More Donor Hearts 3PowerVision Appoints Ophthalmology Thought Leader Douglas D. Koch, M.D. to its Scientific Advisory Board 2PowerVision Appoints Ophthalmology Thought Leader Douglas D. Koch, M.D. to its Scientific Advisory Board 3PowerVision Appoints Ophthalmology Thought Leader Douglas D. Koch, M.D. to its Scientific Advisory Board 4
... (Nasdaq: TELK ) today reported a net loss ... quarter ended September 30, 2011, compared with a net loss ... period in 2010. For the quarter ended September ... with $4.7 million in the third quarter of 2010.  Operating ...
... 2011 Dyadic International, Inc. ("Dyadic") (OTC Pink: ... discovery, development, manufacture and sale of enzyme and ... biopharmaceutical industries, today announced financial results for the ... http://photos.prnewswire.com/prnh/20110621/CL06708LOGO) The financial information contained in ...
Cached Medicine Technology:Telik Announces Third Quarter 2011 Financial Results 2Dyadic International Reports 2011 Third Quarter Financial Results 2Dyadic International Reports 2011 Third Quarter Financial Results 3Dyadic International Reports 2011 Third Quarter Financial Results 4Dyadic International Reports 2011 Third Quarter Financial Results 5Dyadic International Reports 2011 Third Quarter Financial Results 6Dyadic International Reports 2011 Third Quarter Financial Results 7
Form should always follow function. Thats why EagleVision created the FlexPlug, the only tapered shaft punctum plug with contouring traction ribs. Designed to provide the ultimate in flexibility, fix...
The latest wave in punctum plugs! Unique design featureing reservoir indentations to reduce foreign body sensation. Elast™ - a proprietary formulated, hight performance Liquid Silicon Rubber ...
... Attain Prevail's steerable tip, along with various ... obtain the curve you need, when you ... visualization of the cardiac venous anatomy, adjust ... - Adjust curve and reach by ...
... Attain™ Deflectable Catheter - designed to be ... single catheter. Steerablility - Create a variety ... a single, steerable guide catheter. Lock the ... to address each patient's unique anatomy during ...
Medicine Products: